236 related articles for article (PubMed ID: 29950484)
1. AMP-activated protein kinase promotes epithelial-mesenchymal transition in cancer cells through Twist1 upregulation.
Saxena M; Balaji SA; Deshpande N; Ranganathan S; Pillai DM; Hindupur SK; Rangarajan A
J Cell Sci; 2018 Jul; 131(14):. PubMed ID: 29950484
[TBL] [Abstract][Full Text] [Related]
2. Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence.
Tran DD; Corsa CA; Biswas H; Aft RL; Longmore GD
Mol Cancer Res; 2011 Dec; 9(12):1644-57. PubMed ID: 22006115
[TBL] [Abstract][Full Text] [Related]
3. Twist1 and AP-1 cooperatively upregulate integrin α5 expression to induce invasion and the epithelial-mesenchymal transition.
Nam EH; Lee Y; Moon B; Lee JW; Kim S
Carcinogenesis; 2015 Mar; 36(3):327-37. PubMed ID: 25600770
[TBL] [Abstract][Full Text] [Related]
4. Sox5 contributes to prostate cancer metastasis and is a master regulator of TGF-β-induced epithelial mesenchymal transition through controlling Twist1 expression.
Hu J; Tian J; Zhu S; Sun L; Yu J; Tian H; Dong Q; Luo Q; Jiang N; Niu Y; Shang Z
Br J Cancer; 2018 Jan; 118(1):88-97. PubMed ID: 29123266
[TBL] [Abstract][Full Text] [Related]
5. miR-1236 regulates hypoxia-induced epithelial-mesenchymal transition and cell migration/invasion through repressing SENP1 and HDAC3.
Chen SY; Teng SC; Cheng TH; Wu KJ
Cancer Lett; 2016 Aug; 378(1):59-67. PubMed ID: 27177472
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-106b modulates epithelial-mesenchymal transition by targeting TWIST1 in invasive endometrial cancer cell lines.
Dong P; Kaneuchi M; Watari H; Sudo S; Sakuragi N
Mol Carcinog; 2014 May; 53(5):349-59. PubMed ID: 24002805
[TBL] [Abstract][Full Text] [Related]
7. TWIST1-Induced miR-424 Reversibly Drives Mesenchymal Programming while Inhibiting Tumor Initiation.
Drasin DJ; Guarnieri AL; Neelakantan D; Kim J; Cabrera JH; Wang CA; Zaberezhnyy V; Gasparini P; Cascione L; Huebner K; Tan AC; Ford HL
Cancer Res; 2015 May; 75(9):1908-21. PubMed ID: 25716682
[TBL] [Abstract][Full Text] [Related]
8. Loss of BRMS1 promotes a mesenchymal phenotype through NF-κB-dependent regulation of Twist1.
Liu Y; Mayo MW; Xiao A; Hall EH; Amin EB; Kadota K; Adusumilli PS; Jones DR
Mol Cell Biol; 2015 Jan; 35(1):303-17. PubMed ID: 25368381
[TBL] [Abstract][Full Text] [Related]
9. Thymoquinone inhibits cancer metastasis by downregulating TWIST1 expression to reduce epithelial to mesenchymal transition.
Khan MA; Tania M; Wei C; Mei Z; Fu S; Cheng J; Xu J; Fu J
Oncotarget; 2015 Aug; 6(23):19580-91. PubMed ID: 26023736
[TBL] [Abstract][Full Text] [Related]
10. Epithelial-mesenchymal transition induced by TNF-α requires NF-κB-mediated transcriptional upregulation of Twist1.
Li CW; Xia W; Huo L; Lim SO; Wu Y; Hsu JL; Chao CH; Yamaguchi H; Yang NK; Ding Q; Wang Y; Lai YJ; LaBaff AM; Wu TJ; Lin BR; Yang MH; Hortobagyi GN; Hung MC
Cancer Res; 2012 Mar; 72(5):1290-300. PubMed ID: 22253230
[TBL] [Abstract][Full Text] [Related]
11. Scleraxis regulates Twist1 and Snai1 expression in the epithelial-to-mesenchymal transition.
Al-Hattab DS; Safi HA; Nagalingam RS; Bagchi RA; Stecy MT; Czubryt MP
Am J Physiol Heart Circ Physiol; 2018 Sep; 315(3):H658-H668. PubMed ID: 29906225
[TBL] [Abstract][Full Text] [Related]
12. The twist box domain is required for Twist1-induced prostate cancer metastasis.
Gajula RP; Chettiar ST; Williams RD; Thiyagarajan S; Kato Y; Aziz K; Wang R; Gandhi N; Wild AT; Vesuna F; Ma J; Salih T; Cades J; Fertig E; Biswal S; Burns TF; Chung CH; Rudin CM; Herman JM; Hales RK; Raman V; An SS; Tran PT
Mol Cancer Res; 2013 Nov; 11(11):1387-400. PubMed ID: 23982216
[TBL] [Abstract][Full Text] [Related]
13. A ROS/STAT3/HIF-1α signaling cascade mediates EGF-induced TWIST1 expression and prostate cancer cell invasion.
Cho KH; Choi MJ; Jeong KJ; Kim JJ; Hwang MH; Shin SC; Park CG; Lee HY
Prostate; 2014 May; 74(5):528-36. PubMed ID: 24435707
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Twist1-mediated invasion by Chk2 promotes premature senescence in p53-defective cancer cells.
Nayak D; Kumar A; Chakraborty S; Rasool RU; Amin H; Katoch A; Gopinath V; Mahajan V; Zilla MK; Rah B; Gandhi SG; Ali A; Kumar LD; Goswami A
Cell Death Differ; 2017 Jul; 24(7):1275-1287. PubMed ID: 28498365
[TBL] [Abstract][Full Text] [Related]
15. Periostin Mediates TGF-β-Induced Epithelial Mesenchymal Transition in Prostate Cancer Cells.
Hu Q; Tong S; Zhao X; Ding W; Gou Y; Xu K; Sun C; Xia G
Cell Physiol Biochem; 2015; 36(2):799-809. PubMed ID: 26021267
[TBL] [Abstract][Full Text] [Related]
16. Cytoplasmic p27 promotes epithelial-mesenchymal transition and tumor metastasis via STAT3-mediated Twist1 upregulation.
Zhao D; Besser AH; Wander SA; Sun J; Zhou W; Wang B; Ince T; Durante MA; Guo W; Mills G; Theodorescu D; Slingerland J
Oncogene; 2015 Oct; 34(43):5447-59. PubMed ID: 25684140
[TBL] [Abstract][Full Text] [Related]
17. Relationship between circulating tumor cells and epithelial to mesenchymal transition in early breast cancer.
Mego M; Cierna Z; Janega P; Karaba M; Minarik G; Benca J; Sedlácková T; Sieberova G; Gronesova P; Manasova D; Pindak D; Sufliarsky J; Danihel L; Reuben JM; Mardiak J
BMC Cancer; 2015 Jul; 15():533. PubMed ID: 26194471
[TBL] [Abstract][Full Text] [Related]
18. Twist1-induced epithelial-mesenchymal transition according to microsatellite instability status in colon cancer cells.
Oh BY; Kim SY; Lee YS; Hong HK; Kim TW; Kim SH; Lee WY; Cho YB
Oncotarget; 2016 Aug; 7(35):57066-57076. PubMed ID: 27494849
[TBL] [Abstract][Full Text] [Related]
19. MAML1 promotes ESCC aggressiveness through upregulation of EMT marker TWIST1.
Forghanifard MM; Azaraz S; Ardalan Khales S; Morshedi Rad D; Abbaszadegan MR
Mol Biol Rep; 2020 Apr; 47(4):2659-2668. PubMed ID: 32180088
[TBL] [Abstract][Full Text] [Related]
20. Breast tumor cell-specific knockout of
Xu Y; Lee DK; Feng Z; Xu Y; Bu W; Li Y; Liao L; Xu J
Proc Natl Acad Sci U S A; 2017 Oct; 114(43):11494-11499. PubMed ID: 29073077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]